Rheonix Obtains $12,600,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b93cd511-6cfa-4d82-9295-06ba5d32ce7f&Preview=1 -
Date
4/22/2010 -
Company Name
Rheonix -
Mailing Address
22 Thornwood Drive Ithaca, NY 14850 -
Company Description
Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few. Rheonix is not predicated on creating new science; rather its business is bringing to commercial reality the long-promised potential of integrated microfluidic systems. Its unique polymer chip microfluidic technology has produced a wide variety of fluid-handling devices including channels, pumps, reaction vessels, diagnostic chambers, and combinations thereof. -
Website
http://www.rheonix.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,600,000 -
Transaction Round
Series A -
Proceeds Purposes
With this funding, we will focus on scaling the Rheonix CARD system to demonstrate the full commercial potential of our platform. -
M&A Terms
-
Venture Investor
Cayuga Venture Fund -
Venture Investor
Onondaga Venture Capital Fund -
Venture Investor
Rand Capital -
Venture Investor
Undisclosed
